United States Atrial Fibrillation Drugs Market Report 2017

January 2017 | 118 pages | ID: U08072FB7BCEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Atrial Fibrillation Drugs

Revenue, means the sales value of Atrial Fibrillation Drugs

This report studies sales (consumption) of Atrial Fibrillation Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Boehringer Ingelheim
• Janssen Pharmaceuticals
• Sanofi
• ARCA Biopharma
• Armetheon
• Baxter
• Bristol-Myers Squibb
• ChanRx
• Daiichi Sankyo
• Gilead Sciences
• HUYA Biosciences
• Menarini
• Pfizer
• Pierre Fabre
• Servier
• Xention

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Anti-Arrhythmic Drugs
• Anti-Coagulant Drugs

Split by applications, this report focuses on sales, market share and growth rate of Atrial Fibrillation Drugs in each application, can be divided into

• Paroxysmal atrial fibrillation
• Persistent atrial fibrillation
• Longstanding Persistent Afib

Contents

United States Atrial Fibrillation Drugs Market Report 2017

1 ATRIAL FIBRILLATION DRUGS OVERVIEW

1.1 Product Overview and Scope of Atrial Fibrillation Drugs
1.2 Classification of Atrial Fibrillation Drugs
  1.2.1 Anti-Arrhythmic Drugs
  1.2.2 Anti-Coagulant Drugs
1.3 Application of Atrial Fibrillation Drugs
  1.3.1 Paroxysmal atrial fibrillation
  1.3.2 Persistent atrial fibrillation
  1.3.3 Longstanding Persistent Afib
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Atrial Fibrillation Drugs (2011-2021)
  1.4.1 United States Atrial Fibrillation Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Atrial Fibrillation Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES ATRIAL FIBRILLATION DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Atrial Fibrillation Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Atrial Fibrillation Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Atrial Fibrillation Drugs Average Price by Manufactures (2015 and 2016)
2.4 Atrial Fibrillation Drugs Market Competitive Situation and Trends
  2.4.1 Atrial Fibrillation Drugs Market Concentration Rate
  2.4.2 Atrial Fibrillation Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ATRIAL FIBRILLATION DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Atrial Fibrillation Drugs Sales and Market Share by States (2011-2016)
3.2 United States Atrial Fibrillation Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Atrial Fibrillation Drugs Price by States (2011-2016)

4 UNITED STATES ATRIAL FIBRILLATION DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Atrial Fibrillation Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Atrial Fibrillation Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Atrial Fibrillation Drugs Price by Type (2011-2016)
4.4 United States Atrial Fibrillation Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES ATRIAL FIBRILLATION DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Atrial Fibrillation Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Atrial Fibrillation Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES ATRIAL FIBRILLATION DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Boehringer Ingelheim
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.1.2.1 Anti-Arrhythmic Drugs
    6.1.2.2 Anti-Coagulant Drugs
  6.1.3 Boehringer Ingelheim Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Janssen Pharmaceuticals
  6.2.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.2.2.1 Anti-Arrhythmic Drugs
    6.2.2.2 Anti-Coagulant Drugs
  6.2.3 Janssen Pharmaceuticals Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.3.2.1 Anti-Arrhythmic Drugs
    6.3.2.2 Anti-Coagulant Drugs
  6.3.3 Sanofi Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 ARCA Biopharma
  6.4.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.4.2.1 Anti-Arrhythmic Drugs
    6.4.2.2 Anti-Coagulant Drugs
  6.4.3 ARCA Biopharma Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Armetheon
  6.5.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.5.2.1 Anti-Arrhythmic Drugs
    6.5.2.2 Anti-Coagulant Drugs
  6.5.3 Armetheon Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Baxter
  6.6.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.6.2.1 Anti-Arrhythmic Drugs
    6.6.2.2 Anti-Coagulant Drugs
  6.6.3 Baxter Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb
  6.7.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.7.2.1 Anti-Arrhythmic Drugs
    6.7.2.2 Anti-Coagulant Drugs
  6.7.3 Bristol-Myers Squibb Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 ChanRx
  6.8.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.8.2.1 Anti-Arrhythmic Drugs
    6.8.2.2 Anti-Coagulant Drugs
  6.8.3 ChanRx Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Daiichi Sankyo
  6.9.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.9.2.1 Anti-Arrhythmic Drugs
    6.9.2.2 Anti-Coagulant Drugs
  6.9.3 Daiichi Sankyo Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Gilead Sciences
  6.10.2 Atrial Fibrillation Drugs Product Type, Application and Specification
    6.10.2.1 Anti-Arrhythmic Drugs
    6.10.2.2 Anti-Coagulant Drugs
  6.10.3 Gilead Sciences Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 HUYA Biosciences
6.12 Menarini
6.13 Pfizer
6.14 Pierre Fabre
6.15 Servier
6.16 Xention

7 ATRIAL FIBRILLATION DRUGS MANUFACTURING COST ANALYSIS

7.1 Atrial Fibrillation Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Atrial Fibrillation Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Atrial Fibrillation Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Atrial Fibrillation Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ATRIAL FIBRILLATION DRUGS MARKET FORECAST (2016-2021)

11.1 United States Atrial Fibrillation Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Atrial Fibrillation Drugs Sales Forecast by Type (2016-2021)
11.3 United States Atrial Fibrillation Drugs Sales Forecast by Application (2016-2021)
11.4 Atrial Fibrillation Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Atrial Fibrillation Drugs
Table Classification of Atrial Fibrillation Drugs
Figure United States Sales Market Share of Atrial Fibrillation Drugs by Type in 2015
Figure Anti-Arrhythmic Drugs Picture
Figure Anti-Coagulant Drugs Picture
Table Application of Atrial Fibrillation Drugs
Figure United States Sales Market Share of Atrial Fibrillation Drugs by Application in 2015
Figure Paroxysmal atrial fibrillation Examples
Figure Persistent atrial fibrillation Examples
Figure Longstanding Persistent Afib Examples
Figure United States Atrial Fibrillation Drugs Sales and Growth Rate (2011-2021)
Figure United States Atrial Fibrillation Drugs Revenue and Growth Rate (2011-2021)
Table United States Atrial Fibrillation Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Atrial Fibrillation Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Atrial Fibrillation Drugs Sales Share by Manufacturers
Figure 2016 Atrial Fibrillation Drugs Sales Share by Manufacturers
Table United States Atrial Fibrillation Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Atrial Fibrillation Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Atrial Fibrillation Drugs Revenue Share by Manufacturers
Table 2016 United States Atrial Fibrillation Drugs Revenue Share by Manufacturers
Table United States Market Atrial Fibrillation Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Atrial Fibrillation Drugs Average Price of Key Manufacturers in 2015
Figure Atrial Fibrillation Drugs Market Share of Top 3 Manufacturers
Figure Atrial Fibrillation Drugs Market Share of Top 5 Manufacturers
Table United States Atrial Fibrillation Drugs Sales by States (2011-2016)
Table United States Atrial Fibrillation Drugs Sales Share by States (2011-2016)
Figure United States Atrial Fibrillation Drugs Sales Market Share by States in 2015
Table United States Atrial Fibrillation Drugs Revenue and Market Share by States (2011-2016)
Table United States Atrial Fibrillation Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Atrial Fibrillation Drugs by States (2011-2016)
Table United States Atrial Fibrillation Drugs Price by States (2011-2016)
Table United States Atrial Fibrillation Drugs Sales by Type (2011-2016)
Table United States Atrial Fibrillation Drugs Sales Share by Type (2011-2016)
Figure United States Atrial Fibrillation Drugs Sales Market Share by Type in 2015
Table United States Atrial Fibrillation Drugs Revenue and Market Share by Type (2011-2016)
Table United States Atrial Fibrillation Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Atrial Fibrillation Drugs by Type (2011-2016)
Table United States Atrial Fibrillation Drugs Price by Type (2011-2016)
Figure United States Atrial Fibrillation Drugs Sales Growth Rate by Type (2011-2016)
Table United States Atrial Fibrillation Drugs Sales by Application (2011-2016)
Table United States Atrial Fibrillation Drugs Sales Market Share by Application (2011-2016)
Figure United States Atrial Fibrillation Drugs Sales Market Share by Application in 2015
Table United States Atrial Fibrillation Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Atrial Fibrillation Drugs Sales Growth Rate by Application (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Pharmaceuticals Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table ARCA Biopharma Basic Information List
Table ARCA Biopharma Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ARCA Biopharma Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table Armetheon Basic Information List
Table Armetheon Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Armetheon Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table Baxter Basic Information List
Table Baxter Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table ChanRx Basic Information List
Table ChanRx Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ChanRx Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Atrial Fibrillation Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences Atrial Fibrillation Drugs Sales Market Share (2011-2016)
Table HUYA Biosciences Basic Information List
Table Menarini Basic Information List
Table Pfizer Basic Information List
Table Pierre Fabre Basic Information List
Table Servier Basic Information List
Table Xention Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Atrial Fibrillation Drugs
Figure Manufacturing Process Analysis of Atrial Fibrillation Drugs
Figure Atrial Fibrillation Drugs Industrial Chain Analysis
Table Raw Materials Sources of Atrial Fibrillation Drugs Major Manufacturers in 2015
Table Major Buyers of Atrial Fibrillation Drugs
Table Distributors/Traders List
Figure United States Atrial Fibrillation Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Atrial Fibrillation Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Atrial Fibrillation Drugs Production Forecast by Type (2016-2021)
Table United States Atrial Fibrillation Drugs Consumption Forecast by Application (2016-2021)
Table United States Atrial Fibrillation Drugs Sales Forecast by States (2016-2021)
Table United States Atrial Fibrillation Drugs Sales Share Forecast by States (2016-2021)